Surrozen, Inc. Terminates Material Definitive Agreement
Ticker: SRZNW · Form: 8-K · Filed: Oct 17, 2025 · CIK: 1824893
| Field | Detail |
|---|---|
| Company | Surrozen, Inc./De (SRZNW) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $6.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, termination, 8-k
TL;DR
Surrozen terminated a key deal, filing 8-K on Oct 17.
AI Summary
Surrozen, Inc. announced on October 14, 2025, the termination of a material definitive agreement. The company, incorporated in Delaware, filed this 8-K report on October 17, 2025, detailing this event.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's operations, financial standing, and future strategic direction.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement often signals significant business challenges or strategic shifts that could affect the company's future performance.
Key Numbers
- 001-39635 — SEC File Number (Identifies Surrozen's filing with the SEC)
- 30-1374889 — IRS Employer Identification No. (Tax identification for Surrozen)
Key Players & Entities
- Surrozen, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- October 14, 2025 (date) — Date of earliest event reported
- October 17, 2025 (date) — Filing date
- Consonance-HFW Acquisition Corp. (company) — Former company name
FAQ
What specific material definitive agreement was terminated by Surrozen, Inc.?
The filing states the termination of a material definitive agreement but does not specify which agreement was terminated.
What is the effective date of the termination of the material definitive agreement?
The earliest event reported, which is the termination of the material definitive agreement, occurred on October 14, 2025.
When did Surrozen, Inc. file this 8-K report?
Surrozen, Inc. filed this 8-K report on October 17, 2025.
What was Surrozen, Inc.'s former company name?
Surrozen, Inc.'s former company name was Consonance-HFW Acquisition Corp.
In which state is Surrozen, Inc. incorporated?
Surrozen, Inc. is incorporated in Delaware.
Filing Stats: 606 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2025-10-17 16:14:13
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share SRZN The Nasdaq
- $6.0 million — , TCGFB agreed to pay the Company up to $6.0 million in the aggregate, plus any third-party
Filing Documents
- srzn-20251014.htm (8-K) — 45KB
- 0001193125-25-242518.txt ( ) — 183KB
- srzn-20251014.xsd (EX-101.SCH) — 45KB
- srzn-20251014_htm.xml (XML) — 6KB
02 Termination of a Material Definitive Agreement
Item 1.02 Termination of a Material Definitive Agreement. On October 14, 2025, Surrozen, Inc. (the "Company") received notice from TCGFB, Inc. ("TCGFB") that TCGFB has elected to terminate the Collaboration Agreement (the "Collaboration Agreement") between TCGFB and the Company, dated October 31, 2024. TCGFB exercised its right to terminate the Collaboration Agreement for convenience and neither TCGFB nor the Company will incur any termination penalties. The termination will be effective as of November 13, 2025. Under the terms of the Collaboration Agreement, the Company provided antibody discovery services. TCGFB owned all TGF- product related intellectual property. In exchange for the Company's research services, TCGFB agreed to pay the Company up to $6.0 million in the aggregate, plus any third-party costs, and issued the Company a warrant exercisable for up to 3.4 million shares of TCGFB common stock at an exercise price of $0.0001 per share based on certain vesting conditions. TCGFB was founded by The Column Group and the Collaboration Agreement constituted a related party transaction because entities affiliated with The Column Group hold more than 5% of the Company's common stock and Dr. Kutzkey, a member of the Company's board of directors, serves as Managing Partner of The Column Group. The foregoing summary of the terms of the Collaboration Agreement is qualified in its entirety by reference to the Collaboration Agreement, which was filed as Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2024.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SURROZEN, INC. Date: October 17, 2025 By: /s/ Charles Williams Name: Charles Williams Title: Chief Financial Officer, Chief Operating Officer and Corporate Secretary